We are live on ! Find out more
NURE icon

Nuveen Short-Term REIT ETF

18 hedge funds and large institutions have $42.8M invested in Nuveen Short-Term REIT ETF in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $36.4M → $42.8M (+$6.46M)

0% more funds holding

Funds holding: 1818 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

2.98% less ownership

Funds ownership: 88.5%85.52% (-3%)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

Holders
18
Holders Change
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
8
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NURE Hedge Fund Activity: Q2 2020 in Review

18 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Nuveen Short-Term REIT ETF (NURE) for Q2 2020, worth a combined $42.8M — up 18% from $36.4M a quarter earlier.

Fund positioning in NURE was balanced in Q2 2020: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 8 trimmed.

The largest buyer was Gradient Investments, adding an estimated $4.89M. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.15M.

  • 18 institutional investors held Nuveen Short-Term REIT ETF (NURE) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $42.8M of Nuveen Short-Term REIT ETF stock for Q2 2020, up 18% quarter-over-quarter.
  • 1 fund opened new Nuveen Short-Term REIT ETF positions in Q2 2020 and 1 closed out, a net change of 0 holders.
  • The largest Nuveen Short-Term REIT ETF buyer in Q2 2020 was Gradient Investments, an estimated $4.89M added.
  • The largest Nuveen Short-Term REIT ETF seller in Q2 2020 was Tower Research Capital (TRC), an estimated $1.15M sold.

Based on aggregated 13F filings for Q2 2020.